Arlington Trust’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.4K Buy
91
+45
+98% +$5.53K ﹤0.01% 439
2026
Q1
$5.42K Hold
46
﹤0.01% 520
2025
Q4
$7.54K Buy
+46
New +$7.21K ﹤0.01% 340
2025
Q3
Sell
-3
Closed -$373 675
2025
Q2
$373 Buy
+3
New +$382 ﹤0.01% 663
2024
Q4
Sell
-13
Closed -$1.94K 569
2024
Q3
$1.94K Buy
+13
New +$1.86K ﹤0.01% 525

Other funds holding RGEN

Arlington Trust's RGEN Position: Q2 2026 in Review

Arlington Trust increased its Repligen (RGEN) stake by 98% in Q2 2026, buying an estimated $5.53K and bringing the position to 91 shares worth $12.4K. The position accounts for ﹤0.01% of the portfolio, ranked #439.

Arlington Trust first reported a position in RGEN in Q3 2024 and has held it in 5 quarters since. 64 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Arlington Trust held 91 shares of Repligen worth $12.4K as of Q2 2026.
  • Arlington Trust bought 45 Repligen shares in Q2 2026, an estimated $5.53K.
  • Repligen made up ﹤0.01% of Arlington Trust's portfolio in Q2 2026, its #439 holding.
  • Arlington Trust first reported a position in Repligen in Q3 2024 and has held it in 5 quarters since.
  • 64 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Arlington Trust's 13F filing for Q2 2026, filed 7 Jul 2026.